CORDIS · 761828 · H2020
Bronchomycn First in class epithelial Barrier-enhancing medicine for respiratory diseases
Coordinator: EpiEndo Pharmaceuticals ehf (IS)
Chronic obstructive pulmonary disease (COPD) is a respiratory disorder that presents airway epithelial barrier failure (EBF) for which there are no efficient drugs, being a leading cause of chronic morbidity.According to the World Health Organization 64 million people suffered COPD in 2004. The EU-28 and USA accounted for 23 and 12.7 million people respectively, which caused near 200,000 deaths. As a consequence of the medical complications of COPD the economic burden has been estimated as € 48.4 and € 29.3 billion in EU-28 and USA respectivelyEpiEndo, aims at commercializing a new drug which…
About Horizon 2020 (2014–2020)
Horizon 2020 was the EU's flagship research and innovation programme for 2014–2020, with a budget of around €77 billion. It bundled FP7's strands with the EIT and the Competitiveness and Innovation Programme, introduced a stronger societal-challenge orientation, and pushed the funding logic toward closer-to-market innovation. New calls closed in 2020 but funded projects continued through 2024.
Co-funding: the European Union contributes €50k toward a total project budget of €71k — a funding rate of 70%, with the remainder covered by the consortium partners. The project runs over approximately 0.3 years from 2017-02-01 to 2017-05-31.
Full record on CORDIS — partners, deliverables, publications, news.
Open on cordis.europa.eu → Grant DOI ↗More from IS
see all →- WHISPER — Wind Energy Harvesting for Ship Propulsion Assistance and Power101096577 · HORIZON · €9.0M
- MarineGuardian — Advancing Sustainable Fisheries and Marine Ecosystem Conservation in the Atlantic and Arctic Sea basin101212608 · HORIZON · €8.0M
- BioProtect — ADVANCING AREA-BASED MANAGEMENT TOOLS TO ACCELERATE THE PROTECTION AND RESTORATION OF MARINE BIODIVERSITY ACROSS THE EUROPEAN SEA BASINS101157341 · HORIZON · €8.0M
- FUTUREVOLC — A European volcanological supersite in Iceland: a monitoring system and network for the future308377 · FP7 · €6.0M
- FarFish — Responsive Results-Based Management and capacity building for EU Sustainable Fisheries Partnership Agreement- and international waters727891 · H2020 · €5.0M
- LIBBIO — Lupinus mutabilis for Increased Biomass from marginal lands and value for BIOrefineries720726 · H2020 · €4.9M
Other H2020 projects
see all →- EUROfusion — Implementation of activities described in the Roadmap to Fusion during Horizon 2020 through a Joint programme of the members of the EUROfusion consortium633053 · DE · €678.8M
- H2020 — COST at a turning point: A unique framework for pan-European ST cooperation as clear demonstration of European values681463 · BE · €178.2M
- HBP SGA3 — Human Brain Project Specific Grant Agreement 3945539 · BE · €150.0M
- COVID-19 VACCINES — PROPOSAL FOR FUNDING RESEARCH DEVELOPMENT AND MANUFACTURING OF VACCINE AGAINST COVID-19101018100 · NO · €100.0M
- UNITE4TB — ACADEMIA AND INDUSTRY UNITED INNOVATION AND TREATMENT FOR TUBERCULOSIS101007873 · NL · €92.5M
- ERA4TB — EUROPEAN REGIMEN ACCELERATOR FOR TUBERCULOSIS853989 · ES · €89.8M
Frequently asked questions
- Who funds this research project?
- This project is funded by the European Union through the Horizon 2020 (2014–2020) programme, under the SME-1 funding scheme.
- What is the EU contribution?
- The European Commission contributes €50k toward a total project budget of €71k.
- Which EU programme funds it?
- The project is funded under Horizon 2020 (2014–2020), call H2020-SMEInst-2016-2017.
- Who coordinates the project?
- The project is coordinated by EpiEndo Pharmaceuticals ehf (IS).
- What is the project timeline?
- The project runs from 2017-02-01 to 2017-05-31 — approximately 0.3 years.
- Where can I find the full project record?
- The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 761828.